Discovery of Novel Chemotypes to a G-Protein-Coupled Receptor through Ligand-Steered Homology Modeling and Structure-Based Virtual Screening
Citations Over TimeTop 10% of 2008 papers
Abstract
Melanin-concentrating hormone receptor 1 (MCH-R1) is a G-protein-coupled receptor (GPCR) and a target for the development of therapeutics for obesity. The structure-based development of MCH-R1 and other GPCR antagonists is hampered by the lack of an available experimentally determined atomic structure. A ligand-steered homology modeling approach has been developed (where information about existing ligands is used explicitly to shape and optimize the binding site) followed by docking-based virtual screening. Top scoring compounds identified virtually were tested experimentally in an MCH-R1 competitive binding assay, and six novel chemotypes as low micromolar affinity antagonist "hits" were identified. This success rate is more than a 10-fold improvement over random high-throughput screening, which supports our ligand-steered method. Clearly, the ligand-steered homology modeling method reduces the uncertainty of structure modeling for difficult targets like GPCRs.
Related Papers
- → Status of GPCR Modeling and Docking as Reflected by Community-wide GPCR Dock 2010 Assessment(2011)283 cited
- → Discovery of Novel Chemotypes to a G-Protein-Coupled Receptor through Ligand-Steered Homology Modeling and Structure-Based Virtual Screening(2008)169 cited
- → Discovery of novel α-glucosidase inhibitors based on the virtual screening with the homology-modeled protein structure(2007)123 cited
- → IKKβ inhibitors identification part I: Homology model assisted structure based virtual screening(2009)34 cited
- → A benchmarking study on virtual ligand screening against homology models of human GPCRs(2018)1 cited